Efficacy of isobutylamido thiazolyl resorcinol for prevention of laser-induced post-inflammatory hyperpigmentation: a randomized, controlled trial
Phase 4
Completed
- Conditions
- aser-induced post-inflammatory hyperpigmentationSolar lentigines, Q-switched Nd: YaG lasers, Laser-induced post-inflammatory hyperpigmentation, Isobutylamido thiazolyl resorcinol
- Registration Number
- TCTR20230119003
- Lead Sponsor
- Dermatology department, Faculty of Medicine, Ramathibodi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
18 years or older who had solar lentigines on their arms.
Exclusion Criteria
History of laser therapy at the lesions within 3 months prior to the study, active infection or inflammation at the treatment site, immunocompromised status, history of skin cancers or keloids, history of immunosuppressive drugs or vitamin A derivatives used, pregnancy or lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method